A comparative analysis of three pharmacovigilance system assessment tools
PLOS One · 08.07.2025 · 20 (7) · e0327363
DOI: 10.1371/journal.pone.0327363 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PLOS One, online erschienen am 08.07.2025. Verfasst von Muhammad Akhtar Abbas Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Health Services Academy, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Three key tools are currently available for assessing pharmacovigilance systems at the national level: the Indicator-Based Pharmacovigilance Assessment Tool (IPAT), the World Health Organization (WHO) Pharmacovigilance Indicators, and the Vigilance Module of the WHO Global Benchmarking Tool (GBT). These instruments are designed to evaluate the functionality and performance of national regulatory authorities within the context of their respective pharmacovigilance systems.
Objectives
This study aims to identify, analyze, and compare the core characteristics and operational features of these pharmacovigilance assessment tools to better understand their scope, application, and limitations. Methodology A structured document analysis was conducted on the three identified tools. The content was systematically reviewed, categorized, and synthesized to facilitate a comparative evaluation of its design, focus areas, and assessment criteria.
Results
The analysis revealed that the available tools encompass a broad spectrum of indicators targeting different dimensions of pharmacovigilance systems, such as infrastructure, processes, and outcomes. However, exclusive reliance on a single tool may offer a limited perspective, potentially overlooking critical components of a national pharmacovigilance framework.
Conclusion
This study underscores the heterogeneity of existing pharmacovigilance assessment tools and emphasizes the importance of context-specific adaptation. A tailored approach, involving the strategic selection or integration of tools, is recommended to ensure a comprehensive and accurate evaluation of national pharmacovigilance systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Public Health, Health Services Academy, Islamabad, Pakistan.
- Drug Regulatory Authority of Pakistan, Islamabad, Pakistan.
- Promoting the Quality of Medicines Program Plus, United States of America Pharmacopeia, Twinbrook Rockville, Maryland, United States of America.
- College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
ORCID-Profile: Muhammad Akhtar Abbas Khan, Zaheer-Ud-Din Babar
Zitieren
APA
Khan, M. A. A., Nwokike, J., Rauf, A., & Babar, Z. U. (2025). A comparative analysis of three pharmacovigilance system assessment tools. PLOS One, 20(7), e0327363. https://doi.org/10.1371/journal.pone.0327363
Vancouver
Khan MAA, Nwokike J, Rauf A, Babar ZU. A comparative analysis of three pharmacovigilance system assessment tools. PLOS One. 2025;20(7):e0327363. doi:10.1371/journal.pone.0327363
BibTeX
@article{Khan2025,
author = {Khan, Muhammad Akhtar Abbas and Nwokike, Jude and Rauf, Asim and Babar, Zaheer-Ud-Din},
title = {A comparative analysis of three pharmacovigilance system assessment tools},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {7},
pages = {e0327363},
doi = {10.1371/journal.pone.0327363}
}
EUVIMED